Evidence map›Paper›PMID 40388309›Full record

ArticleGigaScience2025

M6Allele: a toolkit for detection of allele-specific RNA N6-methyladenosine modifications.

Yin Zhang, Lin Tang, Shengyao Zhi, Bosu Hu, Zhixiang Zuo, Jian Ren, Yubin Xie, Xiaotong Luo

Abstract read
In one paragraph

Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yin ZhangInnovation Center of the Sixth Affiliated hospital, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0000-0002-8313-3815
Lin TangInnovation Center of the Sixth Affiliated hospital, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0009-0002-7433-6634
Shengyao ZhiGuangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0009-0004-7264-9957
Bosu HuInnovation Center of the Sixth Affiliated hospital, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0009-0000-2279-6837
Zhixiang ZuoState Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0000-0002-2492-2689
Jian RenInnovation Center of the Sixth Affiliated hospital, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0000-0002-4161-1292
Yubin XieInstitute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0000-0002-3566-4849
Xiaotong LuoInnovation Center of the Sixth Affiliated hospital, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, China.ORCID 0000-0002-7367-9910

Funding

Guangdong Pharmaceutical University 2024QZ02Guangzhou Association for Science and Technology QT-2023-045National Key Research and Development Program of China 2023YFC2705900National Natural Science Foundation of China 32200542National Natural Science Foundation of China 82301233
6 · The paper itself

Abstract

backgroundAllelic gene-specific regulatory events are crucial mechanisms in organisms, pivotal to many fundamental biological processes such as embryonic development and chromosome inactivation. Allelic gene imbalance manifests at both RNA expression and epigenetic levels. Recent research has unveiled allelic-specific regulation of RNA N6-methyladenosine (m6A), emphasizing the need for its precise identification. However, prevailing approaches primarily focus on screening allele-specific genetic variations associated with m6A, but not truly identify allelic m6A events. Therefore, the construction of a novel algorithm dedicated to identifying allele-specific m6A (ASm6A) signals is still necessary for comprehensively understanding the regulatory mechanism of ASm6A.

findingsTo address this limitation, we have developed a meta-analysis approach using hierarchical Bayesian models to accurately detect ASm6A events at the peak level from MeRIP-seq data. For user convenience, we introduce a unified analysis pipeline named M6Allele, streamlining the assessment of significant ASm6A across single and paired samples. Applying M6Allele to MeRIP-seq data analysis of pulmonary fibrosis and lung adenocarcinoma reveals enrichment of ASm6A events in key regulatory genes associated with these diseases, suggesting their potential involvement in disease regulation.

conclusionsOur effort provides a method for precisely identifying ASm6A events at the peak level, elucidates the interplay of m6A with human health and disease genetics, and paves a new visual angle for disease research. The M6Allele software is freely available at https://github.com/RenLabBioinformatics/M6Allele under the MIT license.

Indexed as

AdenosineAllelesComputational BiologyRNASoftwareAlgorithmsBayes TheoremHumansAdenosineN-methyladenosineRNAallele-specifichierarchical Bayesian modelmeta-analysisRNA N6-methyladenosine (m6A)

Identifiers

PMID40388309
PMCPMC12087454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.